| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |